| Calculations of the basic and diluted earnings per share from continuing operations |
The calculations of basic and diluted EPS were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended May 31, | | Nine Months Ended May 31, | | (in thousands, except share and per share data) | | 2026 | | 2025 | | 2026 | | 2025 | | Net earnings (loss) | | $ | 173,015 | | | $ | 83,126 | | | $ | 443,329 | | | $ | (67,119) | | | | | | | | | | | | Average basic shares outstanding | | 110,845,841 | | | 112,700,136 | | | 110,955,940 | | | 113,437,950 | | | Effect of dilutive securities | | 869,039 | | | 859,320 | | | 1,023,550 | | | — | | | Average diluted shares outstanding | | 111,714,880 | | | 113,559,456 | | | 111,979,490 | | | 113,437,950 | | | | | | | | | | | Earnings (loss) per share: | | | | | | | | | | Basic | | $ | 1.56 | | | $ | 0.74 | | | $ | 4.00 | | | $ | (0.59) | | | Diluted | | 1.55 | | | 0.73 | | | 3.96 | | | (0.59) | |
For all periods presented except for the nine months ended May 31, 2025, the Company had immaterial anti-dilutive shares, which were not included in the computation of average diluted shares outstanding. For the nine months ended May 31, 2025, the Company had 1,134,029 shares that were excluded from the computation of average diluted shares outstanding due to the Company's net loss position.
|